Skip to main content
. 2020 Aug 15;146(4):790–798. doi: 10.1016/j.jaci.2020.08.008

Fig 3.

Fig 3

Association of allergic diseases with the results of SARS-CoV-2 test (primary outcome) among 291,959 patients, and the association of allergic diseases with clinical outcomes of COVID-19 (secondary outcome) among 7,340 patients who tested positive for SARS-CoV-2. The severe clinical outcomes of COVID-19 comprised admission to the ICU, invasive ventilation, or death. NA, Not applicable/available. The x-axis indicates a log-scale.